Prostate Cell News Volume 17.18 | Oct 2 2026

    0
    19







    2026-10-01 | PCN 17.18


    Prostate Cell News by STEMCELL Technologies
    Vol. 17.18 – 02 October, 2026
    TOP STORY

    Dual Compartmentalization of GSTA4 Suppresses Ferroptosis to Drive Antiandrogen Resistance in Prostate Cancer

    Researchers integrated multi-omics analyses of resistant models and patient specimens, identifying glutathione S-transferase alpha 4 (GSTA4) as a pivotal ferroptosis suppressor that drives antiandrogen resistance in CRPC.
    [Advanced Science]

    Full Article
    Scientists at a scientific conference. Ten ways to make the most of your scientific society membership.
    PUBLICATIONSListed by the impact factor of the journal

    EZH2-Dependent Phenotypic Plasticity Reveals TTP-Associated and mTORC1 Therapeutic Vulnerabilities in Lethal Prostate Cancer

    Scientists identified enhancer of zeste homolog 2 (EZH2)-PI3K/mTORC1 signaling as a therapeutic vulnerability in phenotypically plastic prostate cancer and revealed tristetraprolin (TTP)-associated regulatory programs as contributors to targeted therapy response.
    [Cell Reports Medicine]

    Full Article | Graphical Abstract

    Follistatin Drives AR-Independent Prostate Cancer through BMP Signaling Inactivation and Microenvironmental Remodeling

    The authors identified follistatin, a TGFβ superfamily antagonist, as a key driver of androgen receptor (AR)-independence and treatment resistance in prostate cancer.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    PYGO2 Ablation Promotes Lymphoid Organization and STING-Dependent Antitumor Immunity in Prostate Cancer

    Researchers investigated whether the frequently amplified chromatin effector pygopus 2 (PYGO2) regulates lymphoid organization and antitumor immunity in prostate cancer.
    [Cancer Letters]

    Full Article

    Multiomics Comparison between Prostate Cell Lines and Patient-Derived Tissue to Evaluate Cell Line Clinical Relevance

    Investigators assessed the clinical relevance and inclusivity of 46 prostate cancer cell lines using an integrated clinical and multiomics approach.
    [Communications Medicine]

    Abstract | Full Article

    Senescence-Associated Prostate Cancer Cells Promote Fibroblast Reprogramming and Extracellular Matrix Remodeling

    Scientists integrated human prostate cancer specimens, single-cell RNA-sequencing datasets, a prostate-specific Pten conditional knockout mouse model, mouse single-cell transcriptomics, and mechanistic in vitro experiments to investigate senescence and stromal remodeling.
    [Neoplasia]

    Full Article

    Physiological Elasticity and Topography Modulate In Vitro Prostate Cancer Cell Behavior

    The authors investigated how physiologically relevant mechanical properties affect prostate cancer cells using 2D-poly(dimethylsiloxane) and topographic 2.5D-poly(ethylene glycol) diacrylate-glycidyl methacrylate hydrogel surfaces.
    [iScience]

    Full Article | Graphical Abstract

    TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy Studies

    Researchers investigated whether transient receptor potential melastatin 4 (TRPM4) expression defines Acetalax sensitivity in prostate cancer, comparing TRPM4-high and -low prostate cancer cell lines.
    [Molecular Cancer Therapeutics]

    Abstract

    Integrated Reverse Network Toxicology and Experimental Validation Identify PTP4A3 as a Key Target of Benzo[a]Pyrene in Prostate Cancer

    The authors suggested that benzopyrene could contribute to the acquisition of pro-invasive phenotypes in prostate epithelial cells and potentially to prostate carcinogenesis, probably through upregulating PTP4A3 to activate matrix remodeling programs.
    [Chemico-Biological Interactions]

    Abstract

    Metabolomic Profiling and Anticancer Effects of Red Sea Sponges Liosina granularis and Callyspongia crassa on Prostate and Ovarian Cancer Cells

    Researchers investigated the metabolomic profiles and preliminary anticancer activity of methanolic extracts from two Red Sea sponge species, Liosina granularis and Callyspongia crassa, using prostate and ovarian cancer cell models.
    [Scientific Reports]

    Abstract | Full Article

    Aurora Kinase A Phosphorylates and Stabilizes UHRF1 to Maintain DNA Methylation and Prostate Cancer Cell Survival

    Investigators identified aurora kinase A (AURKA) as a key regulator of global DNA methylation in prostate cancer cells. AURKA depletion markedly reduces genomic 5-methylcytosine levels.
    [Epigenetics]

    Full Article

    Matrine Induces Aggressive Prostate Cancer Cell Death via Inhibition of PPARα Activity: Insights from Transcriptomics, Molecular Docking, and Functional Studies

    Scientists assessed the anti-proliferative effects of matrine in multiple prostate cancer cell lines using CCK-8, EdU, and colony formation assays.
    [Experimental Cell Research]

    Abstract
    Screenshot of a section of the Nature T Cell Nomenclature wallchart
    REVIEWS

    Tumor‑Immune Spatiotemporal Co‑Evolution: A New Paradigm for Understanding and Overcoming Therapy Resistance in Metastatic Castration‑Resistant Prostate Cancer

    The authors propose a spatiotemporal coevolution paradigm, wherein resistance in CRPC emerges not through linear genetic selection alone but through dynamic, reciprocal interactions among tumor cells, stromal components, and immune populations across both temporal and spatial dimensions.
    [International Journal of Molecular Medicine]

    Full Article

    Androgen Receptor-Immune Crosstalk in Metastatic Castration-Resistant Prostate Cancer: From Context-Dependent Remodeling to Biomarker-Guided Translation

    Scientists synthesize mechanistic, translational, and clinical evidence and organize it by cellular compartment, treatment-associated immune state, clinical trial strategy, and biomarker readiness for metastatic CRPC.
    [The Prostate]

    Abstract
    INDUSTRY AND POLICY NEWS

    Prostate Cancer Foundation’s 33rd Annual Scientific Retreat Convenes Leading Experts in Prostate Cancer Research and Care

    The Prostate Cancer Foundation will convene leading researchers, clinicians and industry experts at its 33rd Annual Scientific Retreat. The Retreat is the world’s foremost scientific conference on prostate cancer biology and treatment.
    [Prostate Cancer Foundation (BusinessWire)]

    Press Release

    UNR Med and Renown Advance Cancer Research with Seed Grant Funding

    A new seed-grant fund established in collaboration with Renown Health’s William N. Pennington Cancer Institute has awarded more than $667,000 to researchers, including Dr. Dean Burkin to study a small molecule which could be useful as a treatment modality for prostate cancer.
    [Nevada Today]

    Press Release

    Weill Cornell Medicine Fall Grants Roundup

    Weill Cornell Medicine has received major new funding to support collaborative research, including a $2 million grant to Dr. Scott Tagawa from the Department of Defense to lead Weill Cornell Medicine and NewYork-Presbyterian’s participation in the Prostate Cancer Clinical Trials Consortium.
    [Weill Cornell Medicine]

    Press Release
    FEATURED EVENT

    US Biotech Day

    November 16-17, 2026
    Philadelphia, Pennsylvania, United States

    > See All Events

    JOB OPPORTUNITIES

    Faculty Position – Cancer Immunology

    Mayo Clinic – Phoenix, Arizona, United States

    Postdoctoral Fellow – Genetics, Immunology, and Functional Genomics

    La Jolla Institute for Immunology – San Diego, California, United States

    Assistant Professor – Physiology

    Columbia University Irving Medical Center – New York City, New York, United States

    Group Leader – Cancer Biology

    VIB Center for Cancer Biology – Leuven, Belgium

    Postdoctoral Researcher – Bioinformatics and Cancer Genetics

    University of Gothenburg – Gothenburg, Sweden

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2


    1618 Station Street

    Vancouver, BC, V6A 1B6, Canada

    Unsubscribe or manage your subscriptions.

    View the Science News privacy policy here.